ArticleBMC cardiovascular disorders2026
Association of preoperative albumin-corrected anion gap with 28-day mortality in cardiac surgery patients: a retrospective cohort study.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac surgery patients face significant postoperative risks. The albumin-corrected anion gap (ACAG) has emerged as a potential prognostic marker, but its role in predicting outcomes following cardiac surgery remains understudied. This study examined the association between preoperative ACAG levels and 28-day mortality following ICU admission in patients undergoing cardiac surgery.
methodsThis retrospective cohort study analyzed 5,006 cardiac surgery patients from the MIMIC-IV database. Patients were categorized based on ACAG levels: low (< 12 mmol/L), normal (12–20 mmol/L), and high (> 20 mmol/L). Hierarchical Cox proportional hazards models, restricted cubic spline (RCS) analysis, and exploratory mediation analysis were used to evaluate the association between preoperative ACAG and 28-day mortality following ICU admission. Incremental predictive analyses were additionally performed to assess whether ACAG improved the prognostic performance of models based on SOFA and SAPS II.
resultsElevated ACAG levels (> 20 mmol/L) were significantly associated with a heightened risk of 28-day mortality following ICU admission across all models. In the most comprehensively adjusted model, the hazard ratio was 1.049 (95% CI 1.024–1.075, P < 0.001). ACAG demonstrated superior predictive value for 28-day mortality following ICU admission compared to the traditional anion gap (AUC 0.776 vs. 0.690). RCS revealed a nonlinear relationship, with mortality risk sharply increasing at ACAG levels above 20 mmol/L.In incremental predictive analyses, adding ACAG improved the prognostic performance of both SOFA- and SAPS II-based models. Exploratory mediation analyses suggested that SAPS II, GCS, and several electrolyte-related variables accounted for part of the observed association between preoperative ACAG and 28-day mortality.
conclusionsElevated preoperative ACAG levels were associated with increased 28-day mortality risk in cardiac surgery patients. Although part of this association may reflect overall illness severity and postoperative physiological stress, ACAG may serve as a useful early risk-stratification marker and could complement existing prognostic assessment frameworks. However, its causal role cannot be inferred from this observational study, and prospective studies are needed to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.